Figure 4

Principal component analysis (PCA) of transcriptomes. (A) The PC1 and PC2 explained the major variance of transcriptomes with different treatments. (B) The impact of AhR antagonist, dsAhR and dsKLF10 (dsTieg) on the transcriptomic response to the challenge was better represented by PC3 and PC4.